DIG
KZIA

Dauntless Investment Group’s Kazia Therapeutics KZIA Stock Holding History

Dauntless Investment Group’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.99M Buy
354,208
+274,376
+344% +$3.34M 3.92% 6
2026
Q1 		$594K Buy
79,832
+79,831
+7,983,100% +$556K 0.39% 25
2025
Q4 		$7 Sell
1
-118,138
-100% -$1.01M ﹤0.01% 66
2025
Q3 		$852K Buy
118,139
+2,370
+2% +$19.7K 0.53% 34
2025
Q2 		$726K Buy
+115,769
New +$541K 1.26% 14

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return

Dauntless Investment Group's KZIA Position: Q2 2026 in Review

Dauntless Investment Group increased its Kazia Therapeutics (KZIA) stake by 344% in Q2 2026, buying an estimated $3.34M and bringing the position to 354,208 shares worth $4.99M. The position accounts for 3.92% of the portfolio, ranked #6.

Dauntless Investment Group first reported a position in KZIA in Q2 2025 and has held it in 5 quarters since. 35 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Dauntless Investment Group held 354,208 shares of Kazia Therapeutics worth $4.99M as of Q2 2026.
  • Dauntless Investment Group bought 274,376 Kazia Therapeutics shares in Q2 2026, an estimated $3.34M.
  • Kazia Therapeutics made up 3.92% of Dauntless Investment Group's portfolio in Q2 2026, its #6 holding.
  • Dauntless Investment Group first reported a position in Kazia Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 35 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.